International Dermatology Research, Inc.

Miami, Florida 33174

0 studies enrolling now · 47 studies all time

What they study most

Acne Vulgaris, Actinic Keratoses, Actinic Keratosis, Atopic Dermatitis, Axillary Hyperhidrosis, Cutaneous Common Warts, Hyperhidrosis, Lip Augmentation, Onychomycosis, Pain, Palmar Hyperhidrosis, Plaque Psoriasis

Studies at this site

• Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp Psoriasis — Completed
• Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin) — Completed
• LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs) — Completed
• LEO 90100 Compared With Calcipotriol Plus Betamethasone Dipropionate Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis Vulgaris — Completed
• LEO 90100 in the Treatment of Psoriasis Vulgaris — Completed
• A Study to Investigate ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis — Completed
• Efficacy and Safety of ME3183 in Subjects With Moderate to Severe Plaque Psoriasis — Completed
• Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-301) — Completed
• An Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate to Severe Genital Psoriasis — Completed
• A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis — Completed
• A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis — Completed
• A Study to Investigate Interchangeability of ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis — Completed
• A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA) — Completed
• A Study to Evaluate the Safety and Efficacy of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts — Completed
• A Safety, Tolerability and Preliminary Efficacy Study of BBI-4000 Gel in Subjects With Palmar Hyperhidrosis — Completed
• A Safety and Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis — Completed
• Efficacy and Safety Study of CD2027 Ointment 3 Microgram Per Gram (mcg/g) Twice Daily Treatment for Adults With at Least Moderate Atopic Dermatitis — Completed
• A Study of Glycopyrronium Cloth, 2.4% in Patients With Palmar Hyperhidrosis — Completed
• Study of Glycopyrronium in Axillary Hyperhydrosis — Completed
• Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis — Completed
• A Multicenter, Double-blind, Randomized, Controlled, Roll-over Retreatment Study of the Safety and Pain Associated With Injections of PN40082, RV001 With Topical Anesthetic or RV001 for Lip Augmentation — Stopped early
• A Multicenter, Open-Label Retreatment Study of the Safety and Effectiveness of PN40082 for Lip Augmentation — Completed
• Placebo Controlled Efficacy and Safety Study of CD2475/101 40 mg Tablets vs. Placebo and Doxycycline 100 mg Capsules Once Daily in the Treatment of Inflammatory Lesions of Acne Vulgaris — Completed
• Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1% — Completed
• Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis — Completed
• To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel — Completed
• Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic Dermatitis — Completed
• Clinical Study to Evaluate the Therapeutic Equivalence of Ketoconazole Cream 2% in the Treatment of Tinea Pedis — Completed
• A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis — Completed
• A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 306) — Completed
• DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis — Completed
• Efficacy and Safety Study of 4 Dose Regimens of Oral Albaconazole in Subjects With Distal Subungual Onychomycosis — Completed
• A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis — Stopped early
• BE Study of Naftifine HCL — Completed
• Itraconazole Tablets Vs. Itraconazole Capsules vs. Placebo in Onychomycosis of the Toenail. — Completed
• Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis — Completed
• Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis — Stopped early
• Study to Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis — Completed
• Paired Psoriasis Lesion, Comparative, Study to Evaluate MOL4239 in Psoriasis — Completed
• Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis — Completed
• Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis — Completed
• Safety Study of S-Caine Peel (Skin Numbing Cream) Before a Painful Dermatologic Procedure in Adults — Completed
• A Study of Different Use Regimens Using Two Acne Treatments — Completed
• A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic Keratoses — Completed
• Study of Dose-Effect of COL-121 Ointment in Patients With Plaque-Type Psoriasis — Completed
• A Clinical Study Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris — Completed
• Safety Study of S-Caine Peel (Skin Numbing Cream) Before a Painful Dermatologic Procedure in Children — Completed